- Home
- GH vs BGC Comparison
GH vs BGC Comparison
Compare GH & BGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- BGC
- Stock Information
- Founded
- GH 2011
- BGC 1945
- Country
- GH United States
- BGC United States
- Employees
- GH N/A
- BGC N/A
- Industry
- GH Medical Specialities
- BGC Investment Bankers/Brokers/Service
- Sector
- GH Health Care
- BGC Finance
- Exchange
- GH Nasdaq
- BGC Nasdaq
- Market Cap
- GH 4.9B
- BGC 5.0B
- IPO Year
- GH 2018
- BGC 1999
- Fundamental
- Price
- GH $61.40
- BGC $10.14
- Analyst Decision
- GH Strong Buy
- BGC Strong Buy
- Analyst Count
- GH 16
- BGC 2
- Target Price
- GH $57.50
- BGC $14.50
- AVG Volume (30 Days)
- GH 3.4M
- BGC 3.1M
- Earning Date
- GH 07-30-2025
- BGC 07-31-2025
- Dividend Yield
- GH N/A
- BGC 0.81%
- EPS Growth
- GH N/A
- BGC 38.47
- EPS
- GH N/A
- BGC 0.30
- Revenue
- GH $828,849,000.00
- BGC $2,473,844,000.00
- Revenue This Year
- GH $23.36
- BGC $36.11
- Revenue Next Year
- GH $21.43
- BGC $11.13
- P/E Ratio
- GH N/A
- BGC $33.60
- Revenue Growth
- GH 28.74
- BGC 20.94
- 52 Week Low
- GH $20.14
- BGC $7.24
- 52 Week High
- GH $62.81
- BGC $11.79
- Technical
- Relative Strength Index (RSI)
- GH 72.00
- BGC 52.81
- Support Level
- GH $57.41
- BGC $9.66
- Resistance Level
- GH $59.92
- BGC $10.73
- Average True Range (ATR)
- GH 2.54
- BGC 0.25
- MACD
- GH 0.99
- BGC -0.02
- Stochastic Oscillator
- GH 92.69
- BGC 44.86
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About BGC BGC Group Inc.
BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.